Sage Cerebro

Sage Cerebro is a health technology company focused on early detection and management of neuroinflammation. Our SageSignal™ test applies advanced immunoassay methods and a unique, population-normalized scoring system to capture subtle inflammatory changes before irreversible brain damage occurs. By analyzing multiple biomarkers together, we provide a single, actionable indicator that helps individuals and healthcare professionals make informed decisions to protect and improve cognitive health. Guided by robust research and clinical validation, Sage Cerebro is redefining how we understand cerebrovascular health. Our comprehensive approach—uniting innovative analytics, targeted interventions, and continuous monitoring—equips users with practical tools to stay ahead of potential risks. We believe early insights can empower better outcomes for everyone.